Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Jun;70(6):727-33.
doi: 10.1136/jnnp.70.6.727.

Visual hallucinations in Parkinson's disease: a review and phenomenological survey

Affiliations
Review

Visual hallucinations in Parkinson's disease: a review and phenomenological survey

J Barnes et al. J Neurol Neurosurg Psychiatry. 2001 Jun.

Abstract

Objectives: Between 8% and 40% of patients with Parkinson's disease undergoing long term treatment will have visual hallucinations during the course of their illness. There were two main objectives: firstly, to review the literature on Parkinson's disease and summarise those factors most often associated with hallucinations; secondly, to carry out a clinical comparison of ambulant patients with Parkinson's disease with and without visual hallucinations, and provide a detailed phenomenological analysis of the hallucinations.

Methods: A systematic literature search using standard electronic databases of published surveys and case-control studies was undertaken. In parallel, a two stage questionnaire survey was carried out based on members of a local branch of the Parkinson's Disease Society and followed up with a clinical interview.

Results: The review disclosed common factors associated with visual hallucinations in Parkinson's disease including greater age and duration of illness, cognitive impairment, and depression and sleep disturbances. The survey comprised 21 patients with visual hallucinations and 23 without. The hallucinators had a longer duration and a greater severity of illness, and tended to show more depressed mood and cognitive impairment. The typical visual hallucination in these patients is a complex visual image experienced while they are alert and have their eyes open. The image appears without any known trigger or voluntary effort, is somewhat blurred, and commonly moves. It stays present for a period of "seconds" or "minutes". The content can be variable within and between hallucinators, and includes such entities as people, animals, buildings, or scenery. These features resemble those highlighted in hallucinations in the visually impaired (Charles Bonnet's syndrome).

Conclusion: A consistent set of factors are associated with visual hallucinations in Parkinson's disease. The results of the phenomenological survey and those of visual hallucinations carried out in other settings suggest a common physiological substrate for visual hallucinations but with cognitive factors playing an as yet unspecified role.

PubMed Disclaimer

Similar articles

Cited by

  • Susceptibility to geometrical visual illusions in Parkinson's disorder.
    Wincza R, Hartley C, Readman M, Linkenauger S, Crawford T. Wincza R, et al. Front Psychol. 2024 Jan 8;14:1289160. doi: 10.3389/fpsyg.2023.1289160. eCollection 2023. Front Psychol. 2024. PMID: 38259525 Free PMC article.
  • Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints.
    Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, Paz González JM, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz L LM, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. J Clin Neurol. 2023 Jul;19(4):344-357. doi: 10.3988/jcn.2022.0186. Epub 2023 Jan 2. J Clin Neurol. 2023. PMID: 36647231 Free PMC article.
  • A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease.
    Papapetropoulos S, Katzen H, Schrag A, Singer C, Scanlon BK, Nation D, Guevara A, Levin B. Papapetropoulos S, et al. BMC Neurol. 2008 Jun 20;8:21. doi: 10.1186/1471-2377-8-21. BMC Neurol. 2008. PMID: 18570642 Free PMC article.
  • Alteration in the Local and Global Functional Connectivity of Resting State Networks in Parkinson's Disease.
    Ghahremani M, Yoo J, Chung SJ, Yoo K, Ye JC, Jeong Y. Ghahremani M, et al. J Mov Disord. 2018 Jan;11(1):13-23. doi: 10.14802/jmd.17061. Epub 2018 Jan 23. J Mov Disord. 2018. PMID: 29381889 Free PMC article.
  • Art therapy as a comprehensive complementary treatment for Parkinson's disease.
    Ettinger T, Berberian M, Acosta I, Cucca A, Feigin A, Genovese D, Pollen T, Rieders J, Kilachand R, Gomez C, Kaimal G, Biagioni M, Di Rocco A, Ghilardi FM, Rizzo JR. Ettinger T, et al. Front Hum Neurosci. 2023 May 12;17:1110531. doi: 10.3389/fnhum.2023.1110531. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37250693 Free PMC article.

References

    1. J Neurosci. 1997 Jun 1;17(11):4302-11 - PubMed
    1. Neuropsychology. 1997 Jan;11(1):44-52 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):434-40 - PubMed
    1. Psychiatr Clin North Am. 1997 Dec;20(4):911-31 - PubMed
    1. Neurology. 1998 Feb;50(2):515-7 - PubMed